Default company panoramic image
Logo

NanoMDx.com

Developing next gen. of point-of-care clinical Dx platform capable of identifying 24 genetic targets from a single test under 90 minutes

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Northborough, MA, USA
  • Currency USD
  • Founded October 2011
  • Employees 5
  • Website nanomdx.com

Company Summary

Founded in 2011, we've developed a POC multiplex system, called NEXD, which carries out entire mole. testing steps on a biochip: sample preparation, nucleic acid extraction, amplification, to detection/reporting. NEXD address 3 most significant challenges facing POC: 1) multiplexing--NEXD can detect 24 genetic targets in a test under 90 min.; 2) easy-of-use-NEXD can be used by anyone; 3) low cost- 50% cheaper than current systems on the market .

Team

  • Default avatar
    Karl Qin
    Chief Business Officer

    Mr. Qin is a highly experienced executive in life-science business development, partnership and commercialization. Mr. Qin has more than 17 years of management experiences at leading biotech, specialty pharma and top medical institutes including, Director of Business Development at CDS, Genzyme, and Director of Technology Transfer at MD Anderson Institute, Houston, TX.

  • Default avatar
    Jeanine Ward
    Chief Medical Officer

    Jeanine Ward, MD PhD, servers as a Chief Medical Officer at NanoMDx. She is also an Assistant Professor of Emergency Medicine at the University of Massachusetts Medical School, Worcester, MA, and an attending physician at UMass Memorial Medical Center hospital ER, Worcester, MA.
    Dr. Ward received her PhD in 2002 from the Tufts Sackler School of Biomedical Science, Boston, MA, and later obtained a MD degree from Tufts School of Medicine, Boston,

  • Default avatar
    Ranjit Prakash
    President

    He has over 12 years’ experience in lab-on-a-chip / biochip device development, micro and nano fabrication technology, and systems engineering for diagnostics. Mr. Prakash holds a Bachelor of Engineering degree (Biomedical focus), and a Master of Science degree in Electrical and Computer Engineering (Nanobiotechnology focus).

  • Default avatar
    Kristina McAteer
    Director

    Kristina McAteer, MD, serves as a Director at NanoMDx. She is also an attending Emergency Medicine Physician at Sturdy Memorial Hospital, Attleboro, MA.
    Dr. McAteer graduated with a
    She is board certified in Emergency Medicine and a diplomat of the American Board of Emergency Medicine.

  • Default avatar
    Divakar M
    Director

    He has over 10 years experience in developing clinical bio-chemistry and assays, bio-informatics , with extensive experience in product development in clinical diagnostic requiring FDA 510K approval. He received his PhD in Molecular Biology and completed his post-doctoral work at a Boston based University, MA. He has also authored 14 peer-reviewed publications, 2 book chapters and patents to his credentials.

Advisors

  • Default avatar
    Wilmer-Hale, Boston, MA and Morse, Barnes-Brown & Pendleton, Waltham, MA
    Lawyer
    Unconfirmed